Hemophagocytic Syndrome Secondary to Infection Extrapulmonary Tuberculosis in the Pediatric Population, a Condition Difficult to Diagnose
PDF (Spanish)

Keywords

hemophagocytic syndrome, extrapulmonary tuberculosis, adenosine deaminase.

How to Cite

Hemophagocytic Syndrome Secondary to Infection Extrapulmonary Tuberculosis in the Pediatric Population, a Condition Difficult to Diagnose. (2017). Universitas Medica, 57(3), 367-373. https://doi.org/10.11144/Javeriana.umed57-3.shsi
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar

Abstract

Hemophagocytic lymphohistiocytosis (HLH)
is characterized by activation and proliferation
of lymphocytes or histiocytes, which secondarily exhibit uncontrolled hemophagocytosis and
cytokine overproduction. Acute onset of fever,
generalized lymphadenopathy, hepatosplenomegaly, hypofibrinogenemia and hypertriglyceridemia characterized the syndrome. Its etiology may
be primary or secondary. The primary HLH is
related to genetic factors, and the secondary, associated with infectious, neoplastic and autoimmune processes. The HLH associated infection
occurs predominantly in immunocompromised
patients, and is usually fatal. The vast majority
of cases are reported with herpesvirus infections.
However, a lot of microorganisms are associated
with the etiology. Tuberculosis is an infection recently described as a cause of secondary HLH.
The association between HLH and tuberculosis
is difficult to diagnose. The possibility of finding
the M. tuberculosis in cultured tissue samples
and pleural fluid is very limited because the
extrapulmonary TB is a paucibacillary process.
Among the diagnostic tools to measure levels of adenosine deaminase in pleural fluid has adequate diagnostic sensitivity. Cut-off values are still a
matter of controversy.

PDF (Spanish)

Favara BE, Feller AC, Pauli M, Jaffe ES,

Weiss LM, Arico M, et al. Contemporary

classification of histiocytic disorders.

Med Pediatr Oncol. 1997;29(3):157-66.

Janka GE, Lehmberg K. Hemophagocytic

lymphohistiocytosis: pathogenesis and

treatment. Hematology. 2013;2013(1)

:605-11. doi:10.1182/asheducation-2013.

605

Herrero-Hernández A, Ramírez-Jiménez

S, García-Martín F, Martínez-Valverde

A. Síndromes hemofagocíticos. An Esp

Pediatr. 1998;49:230-6.

Chandrakasan S, Filipovoch A. Hemophagocytic

lymphohistiocytosis: advances

in pathophysiology, diagnosis, and

treatment. J Pediatr. 2013;63(5): 1253-9.

doi: 10.1016/j.jpeds.2013.06.053.

Vaiselbuh S, Bryceson Y, Allen C,

Whitlock J, Abla O. Updates on histiocytic

disorders. Pediatr Blood Cancer.

;61(7):1329-35. doi: 10.1002/

pbc.25017.

Ansuini V, Rigante D, Esposito S. Debate

around infection dependet hemophagocytic

syndrome in paediatrics.

BMC Infect Dis. 2013,13:15. doi:

1186/1471-2334-13-15.

Meets M, Chiang SC, Löfstedt A, Müller

ML, Tesi B, Henter JI, Bryceson

YT. Pathophysiology and spectrum of

diseases caused by defects in lymphocyte

cytotoxicity. Exp Cell Res. 2014

Jul 1;325(1):10-7. doi: 10.1016/j.yexcr.

03.014.

Brastianos PK, Swanson JW, Torbenson

M, Sperati J, Karakousis PC. Tuberculosis-

associated haemophagocytic syndrome.

Lancet Infect Dis 2006; 6(7):447-54.

Janka GE. Familial and acquired hemophagocytic

lymphohistiocytosis. Annu

Rev Med. 2012.63:233-46.

Shea YF, Chan JF, Kwok WC, Hwang

YY, Chan TC, Ni MY, et al. Haemophagocytic

lymphohistiocytosis: an uncommon

clinical presentation of tuberculosis.

Hong Kong Med J. 2012;18(6):517-25.

Henter JI, Elinder G, Óst A. Diagnostic

Guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group

of the Histiocyte Society. Sem Oncol.

;18(1):29-33.

Scott RB, Robb-Smith AHT. Histiocytic

medullar reticulosis. Lancet. 1939;2:

-8.

Henter JI, Horne A, Arico M, et al.

HLH-2004: Diagnostic and therapeutic

guidelines for hemophagocyticlymphohistiocytosis.

Pediatr Blood Cancer.

;48:124-31.

Blanche S. Lymphohistiocytose familiale

et autres síndromes d´activation macrophagique.

Méd Chir (Paris-France),

Pédiatrie. 1995;4-082-J-40:2.

Weintraub M, Siegman-IgraY, Josiphov

J, et al. Histiocytic hemophagocytosis in

miliary tuberculosis. Arch Intern Med.

;144:2055-6.

Yashima A, Narigasawa Y, Ishida Y, et

al. Hemophagocytic syndrome due to

military tuberculosis in the course of

aplastic anemia. JPN J Clin Hematol.

;39:392-7.

Browett PJ, Varcoe AR, Fraser AG, Ellis-

Pegler RB. Disseminated tuberculosis

complicated by the hemophagocytic syndrome.

Aust NZ J Med. 1988;18:79-80.

Seibert AF, Haynes J Jr, Middleton R,

Bass JB Jr. Tuberculous pleural effusion:

twenty year experience. Chest.

;99(4):883-6.

Gilhotra R, Sehgal S, Jindal SK. Pleural

biopsy and adenosine deaminase enzyme

activity in effusions of different aetiologies.

Lung India. 1989;3:122-4.

Nagesh BS, Sehgal S, Jindal SK, et al.

Evaluation of polymerase chain reaction

for detection of Mycobacterium

tuberculosis in pleural fluid. Chest.

;119:1731-41.

Hirschhorn R, Ratech H. Isozymes of

adenosine deaminase. In: Rattazzi MC,

Scandalios JG, Whit GS, editors. Isozymes:

current topics in biological and

medical research. Vol. 4. New York, NY:

Liss; 1980. p. 131-57.

Ungerer JPJ, Oosthuizen HM, Bissbort

SH, et al. Serum adenosine deaminase:

isoenzymes and diagnostic application.

Clin Chem. 1992;38:1322-6.

Mishra OP, Yusuf S, Ali Z, et al. Adenosine

deaminase activity for the diagnosis

of tuberculous effusion in children. J Int

Med Ind. 2000;3:86-9.

Guisti G, Galanti B. Colorimetric method.

In: Bergmeyer HU, editor. Methods of

enzymatic analysis. 3rd ed. Berlin: Verlag

Chemie-Weinheim; 1984. p. 315-23.

Piras MA, Gakis C, Brudoni M, et al.

Adenosine deaminase activity in pleural

effusions: an aid to differential diagnosis.

BMJ. 1978;2:1751-2.

Burgess LJ, Martiz FJ, LeRoux I, et al.

Combined use of pleural adenosine deaminasse

with lymphocyte/neutrophil

ratio: increased specificity for the diagnosis

of tuberculous pleuritis. Chest.

;109:414-9.

This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.

Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.